A Breath of Fresh Air: New Treatment Strategies for Chronic Rhinosinusitis with Nasal Polyps (webcourse)

Format: Webcourse

Credit(s): 1.00 (60 min)

Release Date: Sep 30, 2022

Expiration Date: Sep 30, 2023

Credit Type(s):

Physicians – AMA PRA Category 1 Credit(s) ™
Physicians – prescribed AAFP Credit(s)
Physicians/ABIM MOC – ABIM MOC Point(s)

PROGRAM OVERVIEW

Chronic rhinosinusitis with nasal polyps (CRSwNP) is the most common cause of nasal polyposis, and approximately one third of patients with chronic rhinosinusitis (CRS) will develop nasal polyps. CRSwNP is associated with significant morbidity and negative impacts on patient quality of life, making rapid diagnosis and treatment highly important. Until recently, treatment for CRSwNP has included topical therapy, systemic corticosteroids, and surgery, with minimal efficacy and high morbidity. However, improved understanding of the pathophysiology of CRSwNP has led to the development of numerous biologic therapies that target the inflammatory pathways underlying disease pathogenesis. These agents are more effective and less toxic than historic treatments.

This activity, A Breath of Fresh Air: New Treatment Strategies for Chronic Rhinosinusitis with Nasal Polyps will review the major causes of nasal polyps and how to diagnose CRSwNP, the pathophysiology of CRSwNP, the safety and efficacy of approved treatment options that target the underlying pathophysiology of CRSwNP, and new agents on the horizon.